Are you Dr. Bar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-520-5000Fax+1 206-598-6963
Summary
- Dr. Merav Bar, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington, New Hampshire, and Pennsylvania. She is affiliated with UW Medicine/University of Washington Medical Center and is an Assistant Member at Fred Hutchinson Cancer Research Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2004 - 2006- University of WashingtonResidency, Internal Medicine, 2000 - 2003
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1997
Certifications & Licensure
NH State Medical License 2024 - 2024
WA State Medical License 2002 - 2022
PA State Medical License 2015 - 2016- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
- Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation Start of enrollment: 2002 Sep 01
- Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant Start of enrollment: 2012 Dec 01
- Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 226 citationsLate Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T CellsAna Cordeiro, Evandro D. Bezerra, Alexandre V. Hirayama, Joshua A. Hill, Qian Wu
Biology of Blood and Marrow Transplantation. 2020-01-01 - 111 citationsFactors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama, Salvatore Fiorenza, Alyssa Sheih
Blood. 2021-01-21 - 24 citationsRates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers.Jessica Liang, Stephanie J. Lee, Barry E. Storer, Bronwen E. Shaw, Eric J. Chow
Biology of Blood and Marrow Transplantation. 2019-01-01
